Abera Bioscience

Abera Bioscience ROA

The Return on Assets (ROA) of Abera Bioscience (ABERA.SL) as of Oct 16, 2026 is -36.59 %. In the previous year, Return on Assets (ROA) was -8.09 % — a change of 352.52% (lower).

ROA

-36.59 %

YoY

352.52%

Last updated:

In 2025, Abera Bioscience's return on assets (ROA) was -36.59 %, a 352.52% increase from the -8.09 % ROA in the previous year.

The Abera Bioscience ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-108.81 SEK
Jan 1, 2019
-50.57 SEK
Jan 1, 2020
-122.79 SEK
Jan 1, 2021
-29.21 SEK
Jan 1, 2022
-99.01 SEK
Jan 1, 2023
-178.86 SEK
Jan 1, 2024
-8.09 SEK
Jan 1, 2025
-36.59 SEK
The Abera Bioscience ROA history
YEARROAYoY
-36.59 %+352.52%
-8.09 %-95.48%
-178.86 %+80.65%
-99.01 %+238.93%
-29.21 %-76.21%
-122.79 %+142.83%
-50.57 %-53.53%
-108.81 %+89.38%
-57.46 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Abera Bioscience Stock analysis

What does Abera Bioscience do? Abera Bioscience AB is a biotechnology company based in Uppsala, Sweden, operating within the healthcare sector. The company focuses on the research and development of pharmaceutical products, particularly in the field of vaccine development. It utilizes a proprietary vaccine delivery platform to advance vaccine candidates toward late pre-clinical or early clinical stages. Abera Bioscience aims to identify licensing partners for further development of its vaccine candidates. The company's technology is primarily applied in the development of vaccines targeting pneumococci and immunooncology. Abera Bioscience has a small operational footprint, employing five full-time staff members. It completed its initial public offering (IPO) on February 24, 2021, and is listed under the ticker ABERA.SL with ISIN SE0015245097. The company's headquarters are located in Uppsala, and it operates primarily within the Nordic market. Its website is https://aberabio.com/. The company's activities are centered on advancing vaccine candidates through its platform technology, with an emphasis on strategic partnerships for subsequent development phases. Abera Bioscience is one of the most popular companies on Eulerpool.

ROA Details

Understanding Abera Bioscience's Return on Assets (ROA)

Abera Bioscience's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Abera Bioscience's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Abera Bioscience's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Abera Bioscience’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Abera Bioscience stock

Return on Assets (ROA) of Abera Bioscience is -36.59 % in 2025.

Return on Assets (ROA) of Abera Bioscience changed from -8.09 % to -36.59 %, representing a 352.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Abera Bioscience since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Abera Bioscience with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Abera Bioscience

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Abera Bioscience